Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010387
Status:
COMPLETED
Last Update Posted:
2008-09-10
First Post:
2001-02-02
Brief Title:
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Sponsor:
Johns Hopkins University
Organization:
Office of Rare Diseases ORD
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Autoimmune Diseases |
| Anemia Hemolytic Autoimmune |
| Felty Syndrome |
| Purpura Thrombocytopenic |